Novo’s oral amycretin could lead to more weight loss beyond 12 weeks, according to early-stage trial

Sign up for free to read a limited number of articles each month.

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

A CAR-T deal in China; Zevra’s $60M offering

Plus, news about Ar­row­head, Cul­li­nan Ther­a­peu­tics, Cy­to­ki­net­ics, Zen­tal­is, In­ovio and Mind Med­i­cine: Do­mes­tic biotech M&A in Chi­na: North­east Phar­ma­ceu­ti­cal Group, a decades-old mak­er of gener­ics

Read More »